{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-14",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210601",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "67651",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214900s000lbl.pdf",
              "date": "20210602",
              "type": "Label"
            },
            {
              "id": "67652",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214900Orig1s000ltr.pdf",
              "date": "20210602",
              "type": "Letter"
            },
            {
              "id": "67985",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/214900Orig1s000TOC.html",
              "date": "20210630",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20251103",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "84052",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214900s003lbl.pdf",
              "date": "20251104",
              "type": "Label"
            },
            {
              "id": "84053",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214900s003lbl.pdf#page=18",
              "date": "20251104",
              "type": "Medication Guide"
            },
            {
              "id": "84058",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/214900Orig1s003ltr.pdf",
              "date": "20251104",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20220615",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "71339",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/214900Orig1s001ltr.pdf",
              "date": "20220616",
              "type": "Letter"
            },
            {
              "id": "71342",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214900s001lbl.pdf",
              "date": "20220616",
              "type": "Label"
            },
            {
              "id": "83895",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/214900Orig1s001.pdf",
              "date": "20251023",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20221130",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "72760",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/214900Orig1s002ltr.pdf",
              "date": "20221201",
              "type": "Letter"
            },
            {
              "id": "72776",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214900s002lbl.pdf",
              "date": "20221205",
              "type": "Label"
            },
            {
              "id": "83896",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/214900Orig1s002.pdf",
              "date": "20251023",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA214900",
      "sponsor_name": "GLAXOSMITHKLINE",
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "BREXAFEMME",
          "active_ingredients": [
            {
              "name": "IBREXAFUNGERP CITRATE",
              "strength": "EQ 150MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}